Purpose: Galectin-3 has been implicated in advanced stage of cancer disease. In the current study we examined the possibility of urinary galectin-3 levels to stage cancer disease and to follow up therapy.
Experimental Design: Urine was collected from all types of cancer patients at different stages including patients undergoing radio/chemotherapy.